Tharimmune Historical Balance Sheet

THAR Stock

1.44 0.11 7.10%

Trend analysis of Tharimmune balance sheet accounts such as Total Stockholder Equity of 11 M, Net Tangible Assets of 6.7 M, Accounts Payable of 898.1 K or Cash of 13.2 M provides information on Tharimmune's total assets, liabilities, and equity, which is the actual value of Tharimmune to its prevalent stockholders. By breaking down trends over time using Tharimmune balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining Tharimmune latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Tharimmune is a good buy for the upcoming year.

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Tharimmune. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

To learn how to invest in Tharimmune Stock, please use our How to Invest in Tharimmune guide.

About Tharimmune Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Tharimmune at a specified time, usually calculated after every quarter, six months, or one year. Tharimmune Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Tharimmune and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Tharimmune currently owns. An asset can also be divided into two categories, current and non-current.

Tharimmune Balance Sheet Chart

At this time, Tharimmune's Cash And Short Term Investments are relatively stable compared to the past year. As of 03/23/2025, Common Stock Shares Outstanding is likely to grow to about 105.1 K, though Net Debt is likely to grow to (9.3 M).

Total Assets Short Long Term Debt Total Other Current Liab Total Current Liabilities

Total Assets

Total assets refers to the total amount of Tharimmune assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Tharimmune books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Tharimmune balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Tharimmune are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Most accounts from Tharimmune's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Tharimmune current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Tharimmune. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

To learn how to invest in Tharimmune Stock, please use our How to Invest in Tharimmune guide.At this time, Tharimmune's Cash And Short Term Investments are relatively stable compared to the past year. As of 03/23/2025, Common Stock Shares Outstanding is likely to grow to about 105.1 K, though Net Debt is likely to grow to (9.3 M).

	2024	2025 (projected)
Short and Long Term Debt Total	2.5M	1.8M
Total Assets	12.6M	13.2M

Short Long Term Debt Total Total Assets

Tharimmune balance sheet Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Tangible Assets	Net Debt	Retained Earnings	Accounts Payable	Cash	Long Term Debt	Cash And Short Term Investments	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Net Invested Capital	Short Long Term Debt	Total Current Assets	Capital Stock	Net Working Capital	Short Term Debt	Common Stock	Current Deferred Revenue	Non Currrent Assets Other
Total Assets		0.76	-0.09	0.09	0.98	0.94	-0.98	-0.98	0.65	1.0	0.51	1.0	0.95	-0.78	-0.05	1.0	-0.11	0.99	0.75	1.0	0.91	0.98	0.75	-0.73	0.8	-0.75
Short Long Term Debt Total	0.76		0.35	0.59	0.64	0.61	-0.72	-0.84	0.93	0.74	0.75	0.74	0.65	-0.37	0.49	0.76	0.4	0.68	0.95	0.76	0.81	0.65	0.95	-0.97	0.93	-0.41
Other Current Liab	-0.09	0.35		0.87	-0.28	-0.4	0.21	0.0	0.41	-0.11	0.59	-0.11	0.04	0.61	0.59	-0.09	0.94	-0.22	0.18	-0.09	-0.2	-0.25	0.18	-0.42	0.12	0.0
Total Current Liabilities	0.09	0.59	0.87		-0.11	-0.2	0.02	-0.21	0.74	0.07	0.56	0.07	0.12	0.33	0.88	0.09	0.96	-0.05	0.5	0.09	0.02	-0.09	0.5	-0.63	0.46	-0.08
Total Stockholder Equity	0.98	0.64	-0.28	-0.11		0.98	-0.99	-0.94	0.51	0.98	0.37	0.98	0.92	-0.86	-0.22	0.98	-0.31	1.0	0.66	0.98	0.9	1.0	0.66	-0.59	0.72	-0.72
Net Tangible Assets	0.94	0.61	-0.4	-0.2	0.98		-0.97	-0.9	0.47	0.95	0.31	0.95	0.84	-0.9	-0.24	0.94	-0.4	0.97	0.65	0.94	0.91	0.98	0.65	-0.56	0.7	-0.65
Net Debt	-0.98	-0.72	0.21	0.02	-0.99	-0.97		0.97	-0.59	-0.98	-0.42	-0.98	-0.9	0.84	0.13	-0.98	0.23	-0.99	-0.74	-0.98	-0.94	-0.99	-0.74	0.67	-0.78	0.63
Retained Earnings	-0.98	-0.84	0.0	-0.21	-0.94	-0.9	0.97		-0.74	-0.97	-0.55	-0.97	-0.91	0.73	-0.07	-0.98	0.01	-0.95	-0.84	-0.98	-0.93	-0.94	-0.84	0.81	-0.87	0.62
Accounts Payable	0.65	0.93	0.41	0.74	0.51	0.47	-0.59	-0.74		0.63	0.59	0.63	0.56	-0.35	0.72	0.65	0.55	0.55	0.93	0.65	0.65	0.52	0.93	-0.9	0.93	-0.4
Cash	1.0	0.74	-0.11	0.07	0.98	0.95	-0.98	-0.97	0.63		0.5	1.0	0.95	-0.79	-0.09	1.0	-0.14	0.99	0.73	1.0	0.9	0.99	0.73	-0.71	0.78	-0.75
Long Term Debt	0.51	0.75	0.59	0.56	0.37	0.31	-0.42	-0.55	0.59	0.5		0.5	0.47	0.11	0.28	0.5	0.55	0.41	0.5	0.51	0.43	0.4	0.5	-0.85	0.47	-0.43
Cash And Short Term Investments	1.0	0.74	-0.11	0.07	0.98	0.95	-0.98	-0.97	0.63	1.0	0.5		0.95	-0.79	-0.09	1.0	-0.14	0.99	0.73	1.0	0.9	0.99	0.73	-0.71	0.78	-0.75
Common Stock Shares Outstanding	0.95	0.65	0.04	0.12	0.92	0.84	-0.9	-0.91	0.56	0.95	0.47	0.95		-0.69	-0.12	0.95	-0.05	0.94	0.63	0.95	0.78	0.93	0.63	-0.62	0.69	-0.81
Non Current Liabilities Total	-0.78	-0.37	0.61	0.33	-0.86	-0.9	0.84	0.73	-0.35	-0.79	0.11	-0.79	-0.69		0.23	-0.78	0.56	-0.84	-0.54	-0.78	-0.78	-0.85	-0.54	0.28	-0.61	0.51
Other Current Assets	-0.05	0.49	0.59	0.88	-0.22	-0.24	0.13	-0.07	0.72	-0.09	0.28	-0.09	-0.12	0.23		-0.05	0.82	-0.18	0.51	-0.05	-0.01	-0.22	0.51	-0.5	0.47	0.11
Other Stockholder Equity	1.0	0.76	-0.09	0.09	0.98	0.94	-0.98	-0.98	0.65	1.0	0.5	1.0	0.95	-0.78	-0.05		-0.11	0.99	0.75	1.0	0.91	0.98	0.75	-0.72	0.8	-0.75
Total Liab	-0.11	0.4	0.94	0.96	-0.31	-0.4	0.23	0.01	0.55	-0.14	0.55	-0.14	-0.05	0.56	0.82	-0.11		-0.25	0.26	-0.11	-0.21	-0.29	0.26	-0.48	0.22	0.01
Net Invested Capital	0.99	0.68	-0.22	-0.05	1.0	0.97	-0.99	-0.95	0.55	0.99	0.41	0.99	0.94	-0.84	-0.18	0.99	-0.25		0.69	0.99	0.91	1.0	0.69	-0.63	0.74	-0.74
Short Long Term Debt	0.75	0.95	0.18	0.5	0.66	0.65	-0.74	-0.84	0.93	0.73	0.5	0.73	0.63	-0.54	0.51	0.75	0.26	0.69		0.75	0.85	0.66	1.0	-0.86	0.99	-0.33
Total Current Assets	1.0	0.76	-0.09	0.09	0.98	0.94	-0.98	-0.98	0.65	1.0	0.51	1.0	0.95	-0.78	-0.05	1.0	-0.11	0.99	0.75		0.91	0.98	0.75	-0.73	0.8	-0.75
Capital Stock	0.91	0.81	-0.2	0.02	0.9	0.91	-0.94	-0.93	0.65	0.9	0.43	0.9	0.78	-0.78	-0.01	0.91	-0.21	0.91	0.85	0.91		0.9	0.85	-0.71	0.86	-0.46
Net Working Capital	0.98	0.65	-0.25	-0.09	1.0	0.98	-0.99	-0.94	0.52	0.99	0.4	0.99	0.93	-0.85	-0.22	0.98	-0.29	1.0	0.66	0.98	0.9		0.66	-0.61	0.72	-0.73
Short Term Debt	0.75	0.95	0.18	0.5	0.66	0.65	-0.74	-0.84	0.93	0.73	0.5	0.73	0.63	-0.54	0.51	0.75	0.26	0.69	1.0	0.75	0.85	0.66		-0.86	0.99	-0.33
Common Stock	-0.73	-0.97	-0.42	-0.63	-0.59	-0.56	0.67	0.81	-0.9	-0.71	-0.85	-0.71	-0.62	0.28	-0.5	-0.72	-0.48	-0.63	-0.86	-0.73	-0.71	-0.61	-0.86		-0.84	0.45
Current Deferred Revenue	0.8	0.93	0.12	0.46	0.72	0.7	-0.78	-0.87	0.93	0.78	0.47	0.78	0.69	-0.61	0.47	0.8	0.22	0.74	0.99	0.8	0.86	0.72	0.99	-0.84		-0.41
Non Currrent Assets Other	-0.75	-0.41	0.0	-0.08	-0.72	-0.65	0.63	0.62	-0.4	-0.75	-0.43	-0.75	-0.81	0.51	0.11	-0.75	0.01	-0.74	-0.33	-0.75	-0.46	-0.73	-0.33	0.45	-0.41

Click cells to compare fundamentals

Tharimmune Account Relationship Matchups

Tharimmune balance sheet Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	294.8K	621.7K	6.7M	10.9M	12.6M	13.2M
Other Current Liab	1.6M	1.7M	190.5K	906.5K	815.8K	819.5K
Total Current Liabilities	2.7M	4.5M	1.1M	1.8M	1.6M	1.8M
Total Stockholder Equity	(3.7M)	(4.7M)	5.5M	9.1M	10.5M	11.0M
Net Debt	1.7M	2.2M	(6.5M)	(10.9M)	(9.8M)	(9.3M)
Retained Earnings	(4.7M)	(6.9M)	(15.4M)	(24.7M)	(22.2M)	(21.1M)
Accounts Payable	514.8K	1.5M	954.5K	908.6K	1.0M	898.1K
Cash	191.9K	4.4K	6.5M	10.9M	12.6M	13.2M
Cash And Short Term Investments	191.9K	4.4K	6.5M	10.9M	12.6M	13.2M
Liabilities And Stockholders Equity	294.8K	621.7K	6.7M	10.9M	12.6M	13.2M
Other Current Assets	102.9K	617.3K	178.1K	11.0K	12.7K	12.1K
Other Stockholder Equity	986.4K	2.2M	20.9M	33.8M	38.9M	40.9M
Total Liab	4.0M	5.3M	1.1M	1.8M	1.6M	2.2M
Net Invested Capital	(1.9M)	(2.5M)	5.5M	9.1M	10.5M	11.0M
Total Current Assets	294.8K	621.7K	6.7M	10.9M	12.6M	13.2M
Net Working Capital	(2.4M)	(3.9M)	5.5M	9.1M	10.5M	11.0M

Pair Trading with Tharimmune

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Tharimmune position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tharimmune will appreciate offsetting losses from the drop in the long position's value.

Moving together with Tharimmune Stock

0.79	CDIOW	Cardio Diagnostics	Pair Corr
0.79	ELVN	Enliven Therapeutics	Pair Corr

Moving against Tharimmune Stock

0.8	LUCD	Lucid Diagnostics	Pair Corr
0.75	WM	Waste Management	Pair Corr
0.56	PG	Procter Gamble	Pair Corr
0.54	GE	GE Aerospace	Pair Corr
0.33	PLX	Protalix Biotherapeutics	Pair Corr

The ability to find closely correlated positions to Tharimmune could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Tharimmune when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Tharimmune - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Tharimmune to buy it.

The correlation of Tharimmune is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Tharimmune moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Tharimmune moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Tharimmune can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

Additional Tools for Tharimmune Stock Analysis

When running Tharimmune's price analysis, check to measure Tharimmune's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tharimmune is operating at the current time. Most of Tharimmune's value examination focuses on studying past and present price action to predict the probability of Tharimmune's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tharimmune's price. Additionally, you may evaluate how the addition of Tharimmune to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Tharimmune Historical Balance Sheet

About Tharimmune Balance Sheet Analysis

Tharimmune Balance Sheet Chart

Total Assets

Total Current Liabilities

Tharimmune balance sheet Correlations

Tharimmune Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Tharimmune balance sheet Accounts

Pair Trading with Tharimmune

Moving together with Tharimmune Stock

Moving against Tharimmune Stock

Additional Tools for Tharimmune Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash	+ 1.0	Total Assets
Cash And Short Term Investments	+ 1.0	Total Assets
Other Stockholder Equity	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Assets
Net Invested Capital	+ 1.0	Total Stockholder Equity
Net Working Capital	+ 1.0	Total Stockholder Equity

Net Working Capital	- 0.99	Net Debt
Net Invested Capital	- 0.99	Net Debt
Net Debt	- 0.99	Total Stockholder Equity
Total Current Assets	- 0.98	Retained Earnings
Other Stockholder Equity	- 0.98	Retained Earnings
Total Current Assets	- 0.98	Net Debt